| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Taxes paid related to net share settlement of equity awards | -110,783 | -108,996 |
| Net cash provided by financing activities | 25,915,458 | 993,153 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
| (decrease) increase in cash and cash equivalents | -29,245,877 | -41,461,920 |
| Cash and cash equivalents at beginning of period | 65,813,297 | - |
| Cash and cash equivalents at end of period | 36,567,420 | - |
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)